Neurology · Tampa area, FL
Neurology studies in Tampa area, FL
73 recruiting studies have a site in the Tampa area. This page includes nearby cities such as St. Petersburg, Saint Petersburg, Clearwater, Brandon.
73 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingPhase 2/Phase 3
Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)
DiaMedica Therapeutics Inc
- Location
- Atlantis, FL + 35 other US sites
- Eligibility basics
- Ages 18–90
- RecruitingPhase 3
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
AbbVie
- Location
- Boynton Beach, FL + 87 other US sites
- Eligibility basics
- Ages 6–17
- RecruitingPhase 3
A Study Investigating Intravenous Human Normal Immune Globulin (IGIV) 10% KIg10 (QIVIGY) in Subjects With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Kedrion S.p.A.
- Location
- Miami, FL + 4 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis
Bristol-Myers Squibb
- Location
- Tampa, FL + 4 other US sites
- Eligibility basics
- Ages 10–17
- RecruitingPhase 3
Efficacy and Safety of Intranasal Cenegermin in Adult Participants With Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION)
Dompé Farmaceutici S.p.A
- Location
- Sarasota, FL + 13 other US sites
- Eligibility basics
- Ages 50–80
- RecruitingPhase 2
Usnoflast Neuromuscular Investigation for Treatment Efficacy in Amyotrophic Lateral Sclerosis
Zydus Therapeutics Inc.
- Location
- Tampa, FL + 13 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.
Novartis Pharmaceuticals
- Location
- Altamonte Springs, FL + 42 other US sites
- Eligibility basics
- Ages 40–70
- Recruiting
CAPTURE-2: Controlled Arterial Protection to Ultimately Remove Embolic Material
EmStop Inc
- Location
- Clearwater, FL + 6 other US sites
- Eligibility basics
- Ages 22+
- RecruitingPhase 3
A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-1)
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
- Location
- Clermont, FL + 7 other US sites
- Eligibility basics
- Ages 55–90
- RecruitingPhase 3
A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease
BlueRock Therapeutics
- Location
- Jacksonville, FL + 33 other US sites
- Eligibility basics
- Ages 45–75
- Recruiting
GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients With Patent Foramen Ovale (PFO): the REDUCE Post Approval Study
W.L.Gore & Associates
- Location
- Jacksonville, FL + 30 other US sites
- Eligibility basics
- Ages 18–70
- RecruitingPhase 2
A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Diabetic Peripheral Neuropathic Pain
Eli Lilly and Company
- Location
- Bradenton, FL + 35 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
Eli Lilly and Company
- Location
- Aventura, FL + 41 other US sites
- Eligibility basics
- Ages 55+
- RecruitingPhase 2
A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migraine
AbbVie
- Location
- Miami, FL + 7 other US sites
- Eligibility basics
- Ages 18–70
- RecruitingPhase 2
A Study of TAK-411 in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Takeda
- Location
- Jacksonville, FL + 11 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
ExAblate Blood-Brain Barrier (BBB) Disruption for the Treatment of Alzheimer's Disease
InSightec
- Location
- Delray Beach, FL + 5 other US sites
- Eligibility basics
- Ages 50–85
- RecruitingPhase 2
Study of ALTO-101 in Patients With Schizophrenia
Alto Neuroscience
- Location
- Hollywood, FL + 12 other US sites
- Eligibility basics
- Ages 21–55
- RecruitingPhase 4
A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease
Impax Laboratories, LLC
- Location
- Aventura, FL + 22 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults
SK Life Science, Inc.
- Location
- Tampa, FL + 6 other US sites
- Eligibility basics
- Ages 4–55
- RecruitingPhase 4
Qudexy XR for the Prevention of Migraine in Children 6 to 11 Years Old
Upsher-Smith Laboratories
- Location
- Tampa, FL + 5 other US sites
- Eligibility basics
- Ages 6–11
- Recruiting
Encore PFO Closure Device - The PerFOrm Trial
Encore Medical Inc.
- Location
- Tampa, FL + 7 other US sites
- Eligibility basics
- Ages 18–60
- RecruitingHealthy volunteers
Microbiome in Aging of Gut and Brain
University of South Florida
- Location
- Tampa, FL
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteers
PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
Michael J. Fox Foundation for Parkinson's Research
- Location
- Boca Raton, FL + 29 other US sites
- Eligibility basics
- Ages 30+
- RecruitingHealthy volunteers
Palliative Care Education in Assisted Living for Dementia Care Providers (PCEAL-DCP)
University of South Florida
- Location
- Tampa, FL
- Eligibility basics
- Ages 21+
Who these studies look for
Most require a confirmed diagnosis; memory studies often ask for a study partner who knows you well to attend some visits.
Matching a page like this one never means you qualify. Each research team decides eligibility at screening.